Blueprint Investment Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,712
Closed -$334K 207
2024
Q3
$334K Buy
+3,712
New +$312K 0.06% 130
2024
Q2
Sell
-3,603
Closed -$314K 138
2024
Q1
$314K Buy
+3,603
New +$307K 0.06% 115
2023
Q3
Sell
-2,601
Closed -$229K 137
2023
Q2
$229K Sell
2,601
-769
-23% -$66.2K 0.08% 134
2023
Q1
$272K Buy
+3,370
New +$275K 0.06% 190
2021
Q4
Sell
-2,188
Closed -$274K 251
2021
Q3
$274K Buy
+2,188
New +$283K 0.14% 102

Other funds holding MDT

Blueprint Investment Partners's MDT Position: Q4 2024 in Review

Blueprint Investment Partners sold out of Medtronic (MDT) in Q4 2024, closing a stake of 3,712 shares — an estimated $334K sold.

Blueprint Investment Partners first reported a position in MDT in Q3 2021 and held it in 5 quarters. The position peaked at $334K in Q3 2024. 2,123 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Blueprint Investment Partners reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Blueprint Investment Partners sold 3,712 Medtronic shares in Q4 2024, an estimated $334K.
  • Blueprint Investment Partners first reported a position in Medtronic in Q3 2021 and held it in 5 quarters.
  • Blueprint Investment Partners's Medtronic position peaked at $334K in Q3 2024.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Blueprint Investment Partners's 13F filing for Q4 2024, filed 11 Feb 2025.